Article
Found 2 results
Filters: Keyword is MAPK [Clear All Filters]
. Formononetin inhibits metastatic potential of human prostate cancer cells via upregulating EGR1. Pharmacognosy Magazine [Internet]. 2022;18(80):932-939. http://www.phcog.com/text.asp?2022/18/80/932/361754
PDF (3.58 MB)
. Sugemule-3 protects against isoprenaline-induced cardiotoxicity In vitro. Pharmacognosy Magazine [Internet]. 2017;13(51):517-522. https://www.ncbi.nlm.nih.gov/pubmed/28839382
PDF (1.35 MB)